Literatur
Tselmin S et al. An elevated lipoprotein(a) plasma level as a cardiovascular risk factor. Atheroscler Suppl. 2015;18:257–62
Schatz U et al. Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic. Atheroscler Suppl. 2019; in press
Leebmann J, et al. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation. 2013;128(24):2567–76
Roeseler E et al. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization. Arterioscler Thromb Vasc Biol. 2016;36(9):2019–27
Emmrich U, Hohenstein B, Julius U. Actual situation of lipoprotein apheresis in Saxony in 2013. Atheroscler Suppl. 2015;18:215–25
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schatz, U., Fischer, S., Tselmin, S. et al. Progress trotz Lipoproteinapherese. CV 19, 27–28 (2019). https://doi.org/10.1007/s15027-019-1635-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15027-019-1635-9